Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Allakos Announced A Poster Presentation At The 2024 American Academy Of Allergy, Asthma & Immunology Annual Meeting. The Poster Highlights Preclinical Data Detailing AK006's Mechanism Of Action And Ability To Reduce MRGPRX2-induced Skin Inflammation

Author: Benzinga Newsdesk | February 26, 2024 08:18am

Atopic dermatitis and prurigo nodularis skin lesions show evidence of MRGPRX2 mast cell activation and activated macrophages –
AK006 inhibited mast cell activation and reduced mast cell numbers in an MRGPRX2-induced skin inflammation model

Posted In: ALLK